| Predicate |
Object |
| contentType |
Journal Article |
| endingPage |
1082 |
| issn |
1743-6095 |
| issueIdentifier |
4 Pt 1 |
| pageRange |
1081-1082 |
| publicationName |
The Journal of Sexual Medicine |
| startingPage |
1081 |
| bibliographicCitation |
Levine L. Comment on 'Topical verapamil HCL, topical trifluoroperazine, and topical magnesium sulfate for the treatment of Peyronie's disease--a placebo-controlled pilot study'. J Sex Med. 2007 Jul;4(4 Pt 1):1081–2. doi: 10.1111/j.1743-6109.2007.00539.x. PMID: 17627753. |
| creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_55307d424f25aa25dcccc82e42198614 |
| date |
200707 |
| identifier |
https://pubmed.ncbi.nlm.nih.gov/17627753
https://doi.org/10.1111/j.1743-6109.2007.00539.x |
| isPartOf |
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/32623
https://portal.issn.org/resource/ISSN/1743-6095 |
| language |
English |
| source |
https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/ |
| title |
Comment on 'Topical verapamil HCL, topical trifluoroperazine, and topical magnesium sulfate for the treatment of Peyronie's disease--a placebo-controlled pilot study' |
| discusses |
http://id.nlm.nih.gov/mesh/M0012889
http://id.nlm.nih.gov/mesh/M0022608
http://id.nlm.nih.gov/mesh/M0021955 |
| hasPrimarySubjectTerm |
http://id.nlm.nih.gov/mesh/D014268Q000008
http://id.nlm.nih.gov/mesh/D014700Q000008
http://id.nlm.nih.gov/mesh/D010410
http://id.nlm.nih.gov/mesh/D008278Q000008
http://id.nlm.nih.gov/mesh/D010411Q000188 |
| hasSubjectTerm |
http://id.nlm.nih.gov/mesh/D000287
http://id.nlm.nih.gov/mesh/D008297
http://id.nlm.nih.gov/mesh/D012107
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D004311
http://id.nlm.nih.gov/mesh/D000328 |
| discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62969
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8828
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5566
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24083 |